Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

UroGen Pharma Announces September 2020 Conference Schedule


UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options, today announced that it will present at the following virtual conferences in September:

A live audio webcast of each event will be available on the Investors section of UroGen's website, www.urogen.com. A replay of each webcast will be available on the website for approximately two weeks.

About UroGen Pharma Ltd.

UroGen is a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. UroGen's sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. UroGen's approved product, Jelmyto® (mitomycin) for pyelocalyceal solution, and investigational treatment UGN-102 (mitomycin) for intravesical solution, are designed to ablate tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial cancer and low-grade non-muscle invasive bladder cancer, respectively. UroGen is headquartered in Princeton, NJ with operations in Israel. Visit www.urogen.com to learn more or follow us on Twitter, @UroGenPharma.


These press releases may also interest you

at 04:58
Huawei and UNESCO Expand Opens Schools Project to New Countries
UNESCO and Huawei yesterday launched Phase II of the Technology-Enabled Open Schools for All System (TeOSS) project at the UNESCO Digital Futures of Education Seminar, announcing that the second phase will run from 2024 to 2027 in Brazil, Thailand,...

at 04:30
Abatable partners with the ASEAN Alliance on Carbon Markets
Abatable is pleased to announce a partnership with the ASEAN Alliance on Carbon Markets (AACM). The AACM is an initiative that seeks to promote the growth of voluntary carbon markets across ASEAN (the Association of Southeast Asian Nations) and...

at 04:15
IDTechEx Release New Global Metal-Organic Frameworks Market Report
IDTechEx Research, a trusted provider of independent market intelligence, announces the availability of a new report, "Metal-Organic Frameworks (MOFs) 2024-2034: Market, Technology, and Players". This comprehensive market report offers an...

at 04:05
Faraday Partners with Arm to Innovate AI-driven Vehicle ASICs
Faraday Technology Corporation (TWSE: 3035), a leading provider of ASIC design services and IP solutions, announced it is leveraging the latest Arm® Automotive Enhanced (AE) technology, licensing the Cortex®-A720AE IP to drive the development of...

at 04:05
Looming Deadline for SAP ECC Prompts Nordic Firms to RISE
As the clock winds down on SAP's support for its ERP Central Component (ECC) system, adoption of the company's RISE with SAP offering is on the upswing among Nordic enterprises, according to a new research report published today by Information...

at 04:00
Lord William Hague becomes chair of Hakluyt's international advisory board
Hakluyt, the global strategic advisory firm for businesses and investors, has appointed Lord William Hague as chair of its international advisory board. Lord Hague will succeed Niall FitzGerald KBE, the former CEO and chairman of Unilever, who has...

More news about Science and technology...


News published on and distributed by: